Columbia Tech Ventures 공개
[search 0]
Download the App!
show episodes
 
Artwork

1
Columbia Tech Ventures

Columbia Technology Ventures

Unsubscribe
Unsubscribe
매달
 
Columbia Technology Ventures is the tech transfer office of Columbia University. Our core objective is to facilitate the transfer of inventions from academic research to outside organizations for the benefit of society on a local, national and global basis. Each year, CTV manages more than 330 invention disclosures from faculty, 70 license deals and 15 new start-ups, involving approximately 45 multi-disciplinary, full-time staff across Columbia's two campuses. CTV currently has over 1200 pat ...
  continue reading
 
Loading …
show series
 
Panel discussion with Garrard Beeney (Partner and Co-Head of the Intellectual Property and Technology Group at Sullivan & Cromwell), Ian McClure (Director at the Office of Technology Commercialization at the University of Kentucky, and former IPXI), Phil Hartstein (President and CEO of Finjan), John Veschi (CEO of Marquis Technologies and Former CE…
  continue reading
 
Panel discussion between Sean Dalton (Partner at Highland Capital Partners), Joe Ellis (CEO and Co-Founder of vidRovr), Hemai Parthasarathy (Scientific Director of Breakout Labs, Thiel Foundation), Nina Tandon (CEO and Co-Founder of EpiBone), and Misti Ushio (CEO of TARA Biosystems). The first 35 minutes are largely introductions to each of the pan…
  continue reading
 
On March 4 2016, former U.S. Small Business Administration’s Associate Administrator Javier Saade held an informational session on federal Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR) grants. This session offers insight into the requirements of these highly competitive programs and ways to get an edge when app…
  continue reading
 
Listen to a panel discussion with Jeff Sears (Columbia's Chief Patent Counsel), Ofra Weinberger (Director of Licensing, CTV) and Ron Katz, (Senior Technology Licensing Officer, CTV) to explore invention disclosure, patenting, and the technology commercialization process. moderated by Columbia WIN member Dr. Anjali Saqi, professor of Pathology and C…
  continue reading
 
Columbia Technology Ventures’ Executive Director Orin Herskowitz discusses the fast-changing and ever-growing world of patenting and licensing early-stage university technologies, including examples of scientific inventions, how patent decisions get made, and how license agreements are negotiated, both within Columbia and across the industry.…
  continue reading
 
Featuring a discussion and Q&A with Carlo Rizzuto, operating principal of Versant Ventures, a leading healthcare investment firm investing across the sector at all stages, with an emphasis on early-stage investment in therapeutics. In this video Carlo discusses Versant Ventures’ new $300 million fund for investing in bioscience, as well as other re…
  continue reading
 
While venture capital investment is on the rise, the number of start-ups has also exploded, and competition for VC dollars is fierce. In this podcast, John Lee, Matthew Cohen, Louis P. Berneman of Osage University Partners offer insight into the decision-making process for VC firms and shed light on what VC funding can do for your start-up.…
  continue reading
 
Hear from three current and former federal officials who will offer insight into how the Obama Administration has made innovation a top priority and what this means for the future of entrepreneurship, inside and outside the government. Xavier Hughes (Chief Innovation Officer, U.S. Dept. of Labor), Cheryl Martin (former Acting Director of ARPA-E at …
  continue reading
 
Presenting a panel discussion with Marian Nakada (Johnson & Johnson Innovation – JJDC), Bob Silverman (Roche) and Steven Weinstein (Novartis Ventures), moderated by CTV’s executive director Orin Herskowitz. The conversation touches on the various ways Big Pharma & Biotech are using venture capital investing, regional innovation centers, joint ventu…
  continue reading
 
Presenting a discussion and Q&A with Doug Cole, managing partner of Flagship Ventures, a life science venture fund with over $1.4 billion under management and a new $574 million fund devoted to early-stage therapeutics, health technologies and sustainability. In an interview with CTV’s Executive Director Orin Herskowitz, Doug discusses Flagship Ven…
  continue reading
 
Pull back the curtain and find out how your patent application might hold up under prosecution by the U.S. Patent and Trademark Office (“USPTO”). Columbia University’s Chief Patent Counsel Jeff Sears demonstrates a mock patent examination, showing how the USPTO looks for prior art, evaluates claims made in patent applications, and finally decides w…
  continue reading
 
Loading …

빠른 참조 가이드